Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Make a Passover gift and support Jewish journalism. DONATE NOW
Fast Forward

Gaza Flotilla Boat Eludes Greek Coast Guard

A small ship bound for Gaza eluded the Greek Coast Guard, while a second was intercepted and returned to port.

A small French boat with eight protesters on board left Greek waters Tuesday, the first vessel as part of a Gaza-bound flotilla attempting to break the Israeli naval blockade on the coastal strip.

The “Dignite al Karama” will arrive in international waters near Gaza in about two days, the French news agency AFP reported.

On Monday night, the Canadian ship Tahrir was seized by the Greek Coast Guard minutes after leaving from the port of Agios Nikolaos near Crete. Two of the Canadian passengers and an Australian passenger, who attempted to throw the coast guard off by sailing kayaks near the ship, were arrested.

The ship was reportedly damaged when it slammed into a concrete pier as it was returned to port.

Also on Tuesday, activists from the Spanish flotilla boat reportedly occupied the Spanish Embassy in Athens after meeting with their ambassador to ask their government to pressure the Greek government to allow them to sail.

Leaders of the Gaza-bound flotilla rejected an offer by Greece to deliver aid from the ships stuck in Greek harbors to the coastal strip either through Egypt or Israel, a deal which Palestinian Authority President Mahmoud Abbas reportedly had agreed to.

The ships were to have marked the May 31, 2010 raid of a similar flotilla by Israeli commandos. Nine Turkish activists were killed in the subsequent melee, including a Turkish-American dual citizen.

Israel says the flotilla is illegal and military action to keep it from arriving in Gaza is legitimate. Israel maintains the blockade to keep weapons from flowing into Gaza, which is controlled by Hamas, and also as leverage to secure the freedom of Gilad Shalit, a kidnapped soldier held by Hamas since 2006.

Human rights groups say the blockade keeps out basic foods and medicines, although the Obama administration says its conditions have eased considerably in the last year.

This is a moment of great uncertainty. Here’s what you can do about it.

This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.

With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.

The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

Support our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:

  • Credit the Forward
  • Retain our pixel
  • Preserve our canonical link in Google search
  • Add a noindex tag in Google search

See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.